Targeting the SR-B1 receptor as a gateway for cancer therapy and tumor imaging
Malignant tumors display remarkable heterogeneity to the extent that even at the same tissue site different types of cells with varying genetic background may be found. In contrast, a relatively consistent marker the scavenger receptor type B1 (SR-B1) has been found to be consistently over expressed...
Saved in:
Main Authors: | Linda K Mooberry (Author), Nirupama Avinash Sabnis (Author), Bhavani Nagarajan (Author), Marlyn Panchoo (Author), Andras G Lacko (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2016-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
HDL as a drug and nucleic acid delivery vehicle
by: Andras G Lacko, et al.
Published: (2015) -
Reconstituted HDL: Drug Delivery Platform for Overcoming Biological Barriers to Cancer Therapy
by: Sangram Raut, et al.
Published: (2018) -
The Potential Role of Nanotechnology in Therapeutic Approaches for Triple Negative Breast Cancer
by: Andras G. Lacko, et al.
Published: (2013) -
The role of cholesterol metabolism and cholesterol transport in carcinogenesis; A review of scientific findings, relevant to future cancer therapeutics.
by: Pedro Miguel Cruz, et al.
Published: (2013) -
Mannose-functionalization of reconstituted high-density lipoprotein nanoparticles improves payload delivery and enhances M2-to-M1 phenotype reprogramming of RAW 264.7 macrophages polarized by B16-F10 melanoma cells
by: Akpedje S. Dossou, et al.
Published: (2023)